Christopher Hite, EVP & Vice Chairman at Royalty Pharma plc (RPRX), bought 70,000 shares at $28.00 ($2.0M) on 2020-06-18, disclosed to the SEC on 2020-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RPRX | SELL | 2026-07-02 | $7.3M | — | Filing → |
| RPRX | SELL | 2026-06-25 | $8.2M | — | Filing → |